We would like to thank Dr Mrak for the opportunity to comment on his interesting point that pH meter should be included within the algorithm for the management of marginal ulcers. We agree the Siilin paper contributes to the argument that hyperacidity in the pouch is one of the risk factors for marginal ulceration and that a smaller pouch size results in less acid release and has the potential to reduce marginal ulcer rates [1] . Nevertheless, in the absence of any detectable marginal ulceration, we are unaware of any evidence supporting lifelong acid suppression, although this was not covered in the algorithm, which focused on patients with a diagnosis of marginal ulceration. It would, however, seem reasonable to offer a trail of proton pump inhibitor (PPI) treatment to symptomatic patients, which could be continued if beneficial. We remain unconvinced that measuring pH levels is likely to alter the management in these patients.
In patients with persistent marginal ulcers, hyperacidity, presumably due to a large pouch, could be an important factor. Revision of the pouch should hence form a part of the surgical strategy for some of these patients. Furthermore, whilst Hedberg's paper does support the argument that hyperacidity has a role in the pathogenesis of marginal ulceration five out of six patients were diagnosed with marginal ulcers at 4 weeks or less after their roux en-y bypass [2] . Within our algorithm, all patients would be covered with PPI therapy for a year and so further investigation should be restricted to refractory ulceration and the algorithm followed to address risk factors and correct anatomical abnormalities.
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